Beranda › Kanker (semua jenis) › California › San Francisco
Uji klinis Kanker (semua jenis) di San Francisco, CA
35 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar San Francisco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
PediRISE Feasibility
Menerima peserta
- University of California San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
- Kaiser Permanente-San Francisco, San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of California, San Francisco, San Francisco
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- dan 1 lainnya
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- University of California, San Francisco- California, San Francisco
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Menerima pesertaStudi observasional
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- UCSF, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Menerima pesertaFase 1
- UCSF, San Francisco
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
International Rare Brain Tumor Registry
Menerima pesertaStudi observasional
- University of California San Francisco, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Menerima peserta
- Stanford Cancer Institute, San Francisco
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Menerima pesertaFase 2
- The Unviersity of California, San Francisco (UCSF), San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Menerima pesertaFase 2
- 014, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- UCSF Medical Center at Mission Bay, San Francisco
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- UCSF Medical Center - Mission Bay, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of California-San Francisco, San Francisco
Multisite Implementation of COMPRENDO
Menerima pesertaSukarelawan sehat diterima
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Galleri® in the Medicare Population.
Menerima pesertaSukarelawan sehat diterima
- University of California San Francisco Health System, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- University of California San Francisco (UCSF), San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Menerima pesertaFase 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
Menerima peserta
- University of California, San Francisco, San Francisco
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Primary Tumor Research and Outcomes Network
Menerima pesertaStudi observasional
- UCSF Medical Center, San Francisco
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Menerima pesertaStudi observasional
- University of California San Francisco, San Francisco
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
ChangeGradients: Promoting Adolescent Health Behavior Change
Menerima pesertaSukarelawan sehat diterima
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
Menerima pesertaFase 1
- University of California, San Francisco, San Francisco
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
Studi lain di San Francisco
- Kanker Prostat45 studi
- Kanker Payudara43 studi
- Kanker Paru Non-Sel Kecil36 studi
- Gagal Jantung29 studi
- Kanker Metastatik28 studi
- Kanker Paru22 studi
- Melanoma22 studi
- Kanker Pankreas20 studi
- Kanker Ovarium19 studi
- Kanker Kolorektal18 studi
- Penyakit Kardiovaskular18 studi
- Glioblastoma17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.